These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics. Tan DS; Camilleri-Broët S; Tan EH; Alifano M; Lim WT; Bobbio A; Zhang S; Ng QS; Ang MK; Iyer NG; Takano A; Lim KH; Régnard JF; Tan P; Broët P Int J Cancer; 2014 Sep; 135(5):1092-100. PubMed ID: 24482041 [TBL] [Abstract][Full Text] [Related]
50. Molecular characterization of serous ovarian carcinoma using a multigene next generation sequencing cancer panel approach. Ab Mutalib NS; Syafruddin SE; Md Zain RR; Mohd Dali AZ; Mohd Yunos RI; Saidin S; Jamal R; Mokhtar NM BMC Res Notes; 2014 Nov; 7():805. PubMed ID: 25404506 [TBL] [Abstract][Full Text] [Related]
51. Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative. Lim SM; Kim EY; Kim HR; Ali SM; Greenbowe JR; Shim HS; Chang H; Lim S; Paik S; Cho BC Oncotarget; 2016 Apr; 7(17):24172-8. PubMed ID: 26992220 [TBL] [Abstract][Full Text] [Related]
52. Mutational profiling and immunohistochemical analysis of a surgical series of ampullary carcinomas. Harthimmer MR; Stolborg U; Pfeiffer P; Mortensen MB; Fristrup C; Detlefsen S J Clin Pathol; 2019 Nov; 72(11):762-770. PubMed ID: 31256008 [TBL] [Abstract][Full Text] [Related]
53. Mutation Profile of Resected Zhao ZR; Lin YB; Ng CSH; Zhang R; Wu X; Ou Q; Chen W; Zhou WJ; Lin YB; Su XD; Shao YW; Long H Oncologist; 2019 Oct; 24(10):1368-1374. PubMed ID: 30872465 [TBL] [Abstract][Full Text] [Related]
54. Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A/B loss, and TP53 mutations: A multi-institutional study. Streich L; Sukhanova M; Lu X; Chen YH; Venkataraman G; Mathews S; Zhang S; Kelemen K; Segal J; Gao J; Gordon L; Chen Q; Behdad A Genes Chromosomes Cancer; 2020 Aug; 59(8):484-494. PubMed ID: 32277542 [TBL] [Abstract][Full Text] [Related]
55. Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing. Cai H; Jing C; Chang X; Ding D; Han T; Yang J; Lu Z; Hu X; Liu Z; Wang J; Shang L; Wu S; Meng P; Lin L; Zhao J; Nie M; Yin K J Transl Med; 2019 Jun; 17(1):189. PubMed ID: 31164161 [TBL] [Abstract][Full Text] [Related]
56. Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC. Riess JW; Gandara DR; Frampton GM; Madison R; Peled N; Bufill JA; Dy GK; Ou SI; Stephens PJ; McPherson JD; Lara PN; Burich RA; Ross JS; Miller VA; Ali SM; Mack PC; Schrock AB J Thorac Oncol; 2018 Oct; 13(10):1560-1568. PubMed ID: 29981927 [TBL] [Abstract][Full Text] [Related]
57. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study. Murakami T; Akazawa Y; Yatagai N; Hiromoto T; Sasahara N; Saito T; Sakamoto N; Nagahara A; Yao T Diagn Pathol; 2018 Nov; 13(1):88. PubMed ID: 30458818 [TBL] [Abstract][Full Text] [Related]
58. Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11. La Fleur L; Falk-Sörqvist E; Smeds P; Berglund A; Sundström M; Mattsson JS; Brandén E; Koyi H; Isaksson J; Brunnström H; Nilsson M; Micke P; Moens L; Botling J Lung Cancer; 2019 Apr; 130():50-58. PubMed ID: 30885352 [TBL] [Abstract][Full Text] [Related]
59. Targeted next generation sequencing of MLH1-deficient, MLH1 promoter hypermethylated, and BRAF/RAS-wild-type colorectal adenocarcinomas is effective in detecting tumors with actionable oncogenic gene fusions. Vaňková B; Vaněček T; Ptáková N; Hájková V; Dušek M; Michal M; Švajdler P; Daum O; Daumová M; Michal M; Mezencev R; Švajdler M Genes Chromosomes Cancer; 2020 Oct; 59(10):562-568. PubMed ID: 32427409 [TBL] [Abstract][Full Text] [Related]
60. Somatic STK11 and concomitant STK11/KRAS mutational frequency in stage IV lung adenocarcinoma adrenal metastases. Gleeson FC; Kipp BR; Levy MJ; Voss JS; Campion MB; Minot DM; Tu ZJ; Klee EW; Lazaridis KN; Kerr SE J Thorac Oncol; 2015 Mar; 10(3):531-4. PubMed ID: 25695224 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]